Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).
about
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy and Safety of Sparsen ...... ontrolled Trial Design (DUET).
@en
Efficacy and Safety of Sparsen ...... ontrolled Trial Design (DUET).
@nl
type
label
Efficacy and Safety of Sparsen ...... ontrolled Trial Design (DUET).
@en
Efficacy and Safety of Sparsen ...... ontrolled Trial Design (DUET).
@nl
prefLabel
Efficacy and Safety of Sparsen ...... ontrolled Trial Design (DUET).
@en
Efficacy and Safety of Sparsen ...... ontrolled Trial Design (DUET).
@nl
P2093
P2860
P50
P1433
P1476
Efficacy and Safety of Sparsen ...... ontrolled Trial Design (DUET).
@en
P2093
Alvin Shih
Jennifer L Hunt
Kevin E Meyers
Meghan E MacNally
Pablo Pergola
Peter Nelson
Radko Komers
Sharon Adler
Tarak Srivastava
P2860
P304
P356
10.1016/J.EKIR.2017.02.019
P577
2017-03-04T00:00:00Z